Sunteți pe pagina 1din 12

WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Patial et al. World Journal of Pharmacy and Pharmaceutical Sciences


SJIF Impact Factor 7.421

Volume 7, Issue 10, 680-691 Review Article ISSN 2278 – 4357

ROLE OF PHYTOSOME IN HUMAN HEALTH

Patial Aman*, Rana Malvika and Bhandari Neeraj

Dreamz College of Pharmacy, Mandi Himachal Pradesh.

Article Received on
INTRODUCTION
28 July 2018, Herbal medicines have been widely used all over the world since
Revised on 18 August 2018,
Accepted on 08 Sept. 2018 ancient times and have been recognized by physicians and patients for
DOI: 10.20959/wjpps201810-12435 their better therapeutic or biological value as they have no or fewer
adverse effects as compared with modern medicines. Phytosome is a
*Corresponding Author novel approach to drug delivery system that addresses the limitations
Patial Aman of the traditional drug delivery systems (Suryawanshi, 2011).
Dreamz College of Phytosome is a newly introduced patented technology developed to
Pharmacy, Mandi Himachal
incorporate the standardized plant extracts or water-soluble
Pradesh.
phytoconstituents into phospholipids to produce lipid compatible
molecular complexes called phytosomes (Manach et al., 2004; Habbu et al., 2013 and
Pandey et al., 2010). Most of the biologically active constituents of plants are water soluble
molecules. However, water soluble phytoconstituents (flavonoids, tannins, Xanthones,
Glycosides) are poorly absorbed when taken orally or when applied topically either due to
their large molecular size which cannot be absorbed by passive diffusion or due to their poor
lipid solubility, severely limiting their ability to pass across the lipid‐rich biological
membranes, resulting in poor bioavailability (Manach et al., 2004). Phytosomes provide
better absorption and bioavailability than the conventional herbal extracts. When a
stoichiometric amount of the phospholipid was made to react with purified herbal extract in
an aprotic solvent, phytosomes were formed (Keerthi et al., 2014). Phytosomes, complex of
natural active ingredients and phospholipid increase absorption of herbal extracts or isolated
active ingredients when applied topically or orally. Phytosome are cell like structures which
result from the stoichiometric reaction of the phospholipids (phosphatidylcholine and
phosphatidylserine) with the standardized extract or polyphenolic constituents (flavonoids,
terpenoids, tannins and xanthones) in a non-polar solvent, which are better absorbed, utilized
and as a result produce better results than conventional herbal extracts (Bhattacharya et al.,
2009; Singha et al., 2011). Phospholipids are the main building blocks of life and are one of

www.wjpps.com Vol 7, Issue 10, 2018. 680


Patial et al. World Journal of Pharmacy and Pharmaceutical Sciences

the major components of cellular membranes. In general, they are considered as natural
digestive aid and carriers for both polar and non-polar active substances (Pandey et al.,
2010). Most of phospholipids possess nutritional properties, like phosphatidylserine which
acts as a brain cell nutrient, phosphatidylcholine which is important in liver cell regeneration.
Soya phospholipids have lipid reducing effect and hydrogenated phospholipids serve as basis
for preparation of stable liposomes because of their amphiphilic character (Schmitt and
Lecithin, 2008). Phytosomal formulations enhance the bioavailability of active
phytochemical constituents as they are now permeable and can cross the lipid rich
biomembranes quite easily and the active components of the herbal extracts are well
protected from destruction by digestive secretions and gut bacteria. Therefore, with help of
phytosomal preparations, the amount of standardized plant extracts and phytoconstituents
administered in body through several routes are required in fewer amounts for good
therapeutic activity (Singha et al., 2011). With the advancements in science, the phytosomes
have gained importance in various fields like pharmaceuticals, Cosmeceuticals and
nutraceuticals in preparing different formulations such as solutions, emulsion, creams,
lotions, gels, etc. Several companies involved in production and marketing of phytosome
products’ are Indena, Jamieson natural resources (Neffulusa, 2009). Many approaches have
been developed to improve the oral bioavailability, such as inclusion of solubility and
bioavailability enhancers, structural modification and entrapment with the lipophilic carriers.
The phytosome technology developed by Indena meets this challenge by markedly enhancing
the bioavailability of selected phytomedicines (Venkatesan et al., 2000; Longer et al., 1985;
Sharma et al., 2005).

Rationalization of Phytosome
 The source of Polyphenolic active compound (flavonoids) has been used in traditional
medicine since ancient time against various diseases, including hepatic disorder,
respiratory diseases and rheumatism.
 However the main drawback associated with polyphenolic compounds are their less
absorption from GIT. Less absorption of polyphenolic active compound (flavonoids) is
due to high aqueous solubility and multiple ring arrangement of the molecules which
leads to poor bioavailability. Some of the polyphenolics are highly lipophilic and possess
inadequate dissolution in aqueous GI fluids (Havsteen et al., 2002).
 Thus phytosomes has designed to improved solubility and permeability using
phospholipids.

www.wjpps.com Vol 7, Issue 10, 2018. 681


Patial et al. World Journal of Pharmacy and Pharmaceutical Sciences

 Phytosome approach has shown to overcome such problems and become more
bioavailable as compared to conventional herbal extract owing to their enhanced capacity
to cross the lipoidal biomembrane and finally reaching the systemic circulation. Hence
phytosome is fastly growing attractive way of delivering botanicals based drugs and
neutraceuticals (Bhattacharya and Ghosh, 2009).

Preparation of phytosomes
Phytosome are prepared by reaction of 2-3 moles of phospholipid preferably
phosphatidylcholine or phosphatidylserine with the phytoconstituents like terpenoids
(cafestol) or flavonoids (Catechins or quercetin) in an aprotic solvent such as dioxane, ethyl
acetate or acetone. Lyophilization, freeze drying, precipitation with aliphatic hydrocarbons or
evaporation of solvent under vacuum can be carried out for the isolation. (Loggia et al.,
1996). Phospholipid to phytoconstituents ratio is normally 1:1 to synthesize a phytosome.

www.wjpps.com Vol 7, Issue 10, 2018. 682


Patial et al. World Journal of Pharmacy and Pharmaceutical Sciences

Merits of Phytosomes
1. They enhance the absorption of lipid insoluble polar phytoc8onstituents and shows better
bioavailability; hence they have significantly greater therapeutic benefit.
2. They improve the absorption of active constituent which have further reduce dose
requirements.
3. Phosphatidylcholine used in preparation of phytosomes, besides acting as a carrier also
acts as a hepatoprotective, hence giving the synergistic effect when the hepatoprotective
substances are employed.
4. Chemical bonds are formed between phosphatidylcholine molecules which added
nutritional benefit of phospholipids.
5. They have appreciable drug entrapment.
6. Significantly greater clinical benefits.
7. Assured delivery to the tissue. (Srikanth et al., 2011)

Demerits of Phytosome
Phytoconstituent is rapidly eliminated from phytosome (Saha et al., 2013 and Battacharya
et al., 2009).

www.wjpps.com Vol 7, Issue 10, 2018. 683


Patial et al. World Journal of Pharmacy and Pharmaceutical Sciences

Properties of Phytosomes
Following are some of the important properties of phytosomes:

Physiochemical properties
1. Phytosomes are prepared by reaction of stoichiometric amount of phospholipid with the
standardized plant extracts as substrate. The spectroscopic data reveals that the
phospholipid substrate interaction is due to the formation of hydrogen bond between the
polar head (i.e., phosphate and ammonium group) and the polar functionalities of the
substrate (Tripathy et al., 2013).

2. The size of Phytosome varies from 50 nm to a few 100μm (Patel et al., 2013).
3. Phytosome when treated with water assumes a micellar (spherical) shape resembling
liposome and photon correlation spectroscopy (PCS) reveals this liposomal structures
acquired by phytosome (Jain, 2005).
4. The H1NMR and C13 NMR data deduced that the fatty chain gives unchanged signals
both in free phospholipid and in the complex, which indicates that long aliphatic chains
are wrapped around the active principle producing lipophilic envelope (Dayan and
Touitou, 2000).
5. The complexes are often freely soluble in aprotic solvents (Chloroform and
Dimethylsulfoxide) moderately soluble in fats, insoluble in water and relatively unstable
in alcohol. But the phytosomes of certain lipophilic phytoconstituents like curcumin has
shown increase in water solubility upon complexation with phospholipid (Maffei et al.,
1994).

Biological properties
Phytosome are novel complexes which are better absorbed and utilized; hence they produce
more bioavailability and better result than the conventional herbal extract or non-complex

www.wjpps.com Vol 7, Issue 10, 2018. 684


Patial et al. World Journal of Pharmacy and Pharmaceutical Sciences

extracts, which has been demonstrated by pharmacokinetic studies or by pharmacodynamic


tests in experimental animals and in human subjects (Maffei et al., 1994).

Evaluation of Phytosomes
Characterization
The following are the characterization techniques used for Phytosomes in characterizing its
physical attributes.

 Visualization: Visualization of phytosomes can be achieved using transmission electron


microscopy (TEM) and by scanning electron microscopy (SEM) (Fry et al., 1978).
 Particle size and Zeta potential: The particle size and zeta potential can be determined
by dynamic light scattering (DLS) using a computerized inspection system and photon
correlation spectroscopy (PCS) (Lars et al., 2002).
 Entrapment efficiency: The entrapment efficiency of a drug in phytosomes can be
measured by the ultracentrifugation technique (Lars et al., 2002).
 Transition temperature: The transition temperature of the vesicular lipid systems can be
determined by differential scanning calorimetry (Gregor et al., 1995).
 Surface tension activity measurement: The surface tension activity of the drug in
aqueous solution can be measured by the ring method in a Du Nouy ring tensiometer
(Van den Bergh et al., 1997).
 Vesicle stability: The stability of vesicles can be determined by assessing the size and
structure of the vesicles over time. The mean size is measured by DLS and structural
changes are monitored by TEM (Dayan et al., 2000).
 Drug content: The amount of drug can be quantified by a modified high performance
liquid chromatographic method or by a suitable spectroscopic method (Maffei et al.,
1994).

2) Spectroscopic Evaluation
The spectroscopic evaluations are widely employed in order to confirm the formation of
complex between phytoconstituents and the phospholipid moiety as well as to study the
corresponding interaction between the two.

1
 H-NMR: The complex formation between the active phytoconstituents and the
phosphatidylcholine molecule can be estimated by this method. Bombardelli et al.,
studied the NMR spectra of phytosome complex in non polar solvents. There is a marked

www.wjpps.com Vol 7, Issue 10, 2018. 685


Patial et al. World Journal of Pharmacy and Pharmaceutical Sciences

change in 1H-NMR signal originating from atoms involved in the formation of complex,
without any summation of the signal peculiar to individual molecules. The signals from
protons belonging to the phytoconstituents are broadened. In phospholipids there is
broadening of signals while the singlet corresponding to the N-(CH3)3 of choline
undergoes an up field shift (Bombardelli et al., 1991).

13
 C-NMR: In the 13C NMR of the phytoconstituents and the stoichiometric complex
with the phosphatidylcholine when recorded in C6D6 at room temperature all the
phytoconstituents carbons were invisible. The signals corresponding to the glycerol and
choline portion are broadened and some are shifted, while most of the resonance of the
fatty acid chains retains their original sharp line shape.

 FTIR: The formation of the complex can be also be confirmed by IR spectroscopy by


comparing the spectrum of the complex with the spectrum of the individual components
and their mechanical mixtures. FTIR spectroscopy is also a useful tool for the control of
the stability of phytosomes when micro-dispersed in water or when incorporated in very
simple cosmetic gels. From a practical point of view, the stability can be confirmed by
comparing the spectrum of the complex in solid form (phytosomes) with the spectrum of
its micro-dispersion in water after lyophilization, at different times. In the case of simple
formulations, it is necessary to subtract the spectrum of the excipients (blank) from the
spectrum of the cosmetic form at different times, comparing the remaining spectrum of
the complex itself.

Successful product
S. No. Natural Source Phyto-constituents Pharmacological action Dose forms/Dose Reference
Withanolides
(Steroidal lactones):
Antibacterial,
Withanone, withaferin A,
antioxidant, aphrodisiac, Ashwagandha Keerthi et
1 Ashwagandha withanolides.
liver tonic and anti- phytosomes. al., 2014
Alkaloids: ashwagandhine,
inflammatory
cuscohygrine, anahygrine,
ropine.
Antioxident,
Rutin Vankudri et
2 Rutin quercitine glycoside antiplatelate and
phytosome/100 mg al., 2016
Antidiabetic
Boswellic acid
phytosome
Boswellia Antimicrobial and Sahu A.R et
3 Carrier:lecithin,
Serrata Counter irritant activities al., 2015
Phospholipon 90 G,
cholesterol
4 Silybium Silybin, Silycristin, Isosilibin, Hepatoprotective, Silybin Farinacci et

www.wjpps.com Vol 7, Issue 10, 2018. 686


Patial et al. World Journal of Pharmacy and Pharmaceutical Sciences

maranium Silydianin, silibinin cirrhosis and acute and phytosomeTM al., 2009
chronic inflammation (Siliphos ®)/ 120- (22)
200 mg
Neutraceutical,
Epigalloctechin, catechin, Anticancer, Antioxidant, Green tea
Camellia Pierro et al.,
5 epicatechin-3-O-gallate, Hepatoprotective, Anti- PhytosomesTM /400
sinensis (Tea) 2009 (25)
epigalloctechin-3-O-gallate diabetic and anti- mg
inflammatory
Cognition enhancer,
Gingko flavonoids, Gingoic Raynaud’s disease, Gingkoselect
Pandey et
6 Gingko biloba acid of Antiasthmathic, PhytosomeTM /120
al., 2010
gingkoflavonglucosides cardioprotectives, mg
antiinflammatory.
Crateegus Nutraceutical, Hawthron
Pandey et
7 oxyacanthoides Hyperin, Quercitin Cardioprotective and PhytosomeTM /100
al., 2010
(Hawthron) antihypertensive mg
Antioxident,
Olea europaea Oleaselect Pandey et
8 Verbascosides, tryosol antihyperlipidimic,
(olive tree) PhytosomeTM al., 2010
anticancer
Echinacea Echinacosides and high
Nutraceutical, Echinacea Bombardell
9 angustifolia molecular weight
Immunomodulator PhytosomeTM et al., 1991
(Cone flower) polysaccharides(inulin)
Terminalia Anti –aging, wound Sericoside
Bombardeli
10 serica (Silver Sericoside healing, antioedema, PhytosomeTM /3%
et al., 1974
cluster leaf) anti-inflammatory gel
Anti-inflammatory,
Glycyrrhiza Glycyrrhetinic acid Pandey et
11 Glycyrrhetinic acid antierythemic, anti-
glabra (Mulethi) PhytosomeTM al., 2010
irritant, skin infection
Centella triterpinoid
Centella asiatica Skin disorder, antiulcer, Bombardeli
12 Asiatic acid PhytosomeTM /60-
(Brahmi) wound healing et al., 1974
120 mg
Curcumin
Curcuma longa Anti- inflammatory, PhytosomeTM , Kohli et al.,
13 Curcumin
(turmeric) osteoarthritis, anticancer Curcuvet® /250 mg 2005
and 360
Naringenin
Citrus aurantium Maiti et al.,
14 Naringenin Antioxidant PhytosomeTM/100m
(bitter orange) 2006
g/kg
Swertia Swertia Havsteen et
15 Xanthones 26 Antioxidant
alternifolia PhytosomeTM- al., 2002
Anti- inflammatory,
Vaccinum
Antioxidant, Mirtoselect
16 myrtillus 5,26
Anthocyanosides vasoprotective, PhytosomeTM
(Bilbery)
antidiabetic
Serenoa repens Non – cancerous Salbalselect
Pandey et
17 (Saw palmetto Phytosterols prostate enlargement, PhytosomesTM /320
al., 2010
berries anticancer mg
Melilotus Anti- inflammatory,
Melilotoside, flavanoid and LymphaselectTM /2 Pandey et
18 officinalis (sweet antioedema,
terpenoids to 60 mg al., 2010
clover) thrombophlebitis
Ammi visnaga Microcirculation Pandey et
19 Visnadine VisnadexTM
(Khella) improver, anticellulite al., 2010
Santalum album Ximenynic acid, ethyl Microcirculation Ximilene Bombardeli
20
(Sandal wood ximenynate improver Ximenoil et al., 1974

www.wjpps.com Vol 7, Issue 10, 2018. 687


Patial et al. World Journal of Pharmacy and Pharmaceutical Sciences

PhytosomesTM
Vasoactive,
Fraxinus ornus Esculoside
21 Esculoside (Esculin) Microcirculation Saha et al.,
(Flowering ash) PhytosomesTM
improver, anticellulite
Puerarin and
Radix puerariae Anti inflammatory, Battacharya
22 Puerarin phospholipid
(kudzu root) cardiovascular diseases et al., 2009
complex
Panicum Mineral salts, vitamins,
Antistress, bcauty food Millet Pandey et
23 miliaceum unsaturated fatty acid,
for skin, nails and hairs PhytosomesTM al., 2010
(Millet) aminoacid
Vaccinium Anthocyanoside tocotrienol Antioxidant, improves
Vita Blue Pandey et
24 angustifolium complex, citrus bioflavonoid, vision, memory
PhytosomesTM al., 2010
(Blue berry) alpha lipoic acid enhancer
Immunomodulator
Ginseng Pandey et
25 Panax ginseng Ginsenosides activities and
PhytosomesTM al., 2010
neutraceutical

CONCLUSION
The effectiveness of herbal extracts in terms of potency can be improved by the value added
phytosome formulations which is a patented technology (Indena, Italy) also known as
herbosome. For gastrointestinal absorption a drug should have sufficient water solubility and
lipid solubility. The polyphenolic flavonoids are well known for their diverse therapeutic
effects but either less water solubility or insufficient lipid solubility are the hurdles in
developing dosage form. Problems of this type are avoidable through the benefits of this new
technology. Therapeutic effect of herbal constituent can be obtained at significantly lower
dose in comparison to conventional herbal extract. The review enlightened the ongoing
research and also through rays of hope that in near future many of the traditional herbal
extract can be converted to effective modern medicine.

REFERENCES
1. J. A. Saonere Suryawanshi., 2011; “Phytosome: An emerging trend in herbal drug
treatment”. Journal of Medical Genetics and Genomics, August 2011; 3(6): 109-114.
2. Manach C, Scalbert A, Morand C, Polyphenols, food sources and bioavailability,
American journal of clinical nutrition, 2004; 9: 727-747.
3. Prasanna Habbu, Smita Madagundi, Ramesh Kulkarni, Preparation and evaluation of
Bacopae phospholipid complex for antiamnesic activity in rodents, Drug invention today,
2013; 5: 13-21.
4. Pandey S, Patel K, Phytosomes: Technical revolution in phytomedicine, International
journal of Pharm Tech Research, 2010; 6: 627‐31.

www.wjpps.com Vol 7, Issue 10, 2018. 688


Patial et al. World Journal of Pharmacy and Pharmaceutical Sciences

5. Keerthi B, Prasuna Sundari Pingali, Dr. Prathima Srinivas, 2014; “Formulation and
Evaluation of Capsules of Ashwagandha Phytosomes” Int. J. Pharm. Sci. Rev. Res.,
29(2), November – December 2014; Article No. 25, Pages: 138-142.
6. Bhattacharya S. Phytosomes: emerging strategy in delivery of herbal drugs and
nutraceuticals. Pharma Times, 2009; 41: 9-12.
7. Anupama Singha, Vikas Anand Saharanb, Manjeet Singha, Anil Bhandaria: Phytosome:
Drug Delivery System for Polyphenolic Phytoconstituents Iranian Journal of
Pharmaceutical Sciences Autumn, 2011; 7(4): 209-219.
8. Pandey S, Patel K. Phytosomes: technical revolution in phytomedicine. Int J Pharm Tech
Res., 2010; 2: 627-31.
9. Tripathy S, Patel D, Baro L, Nair S (2013) A review on phytosomes, their
characterization, advancement and potential for transdermal application, Journal of Drug
Delivery and Therapeutics, 2013; 3: 147-152.
10. Patel A, Tanwar Y, Rakesh S, Patel P (2013) Phytosome: Phytolipid Drug Delivery
System for Improving Bioavailability of Herbal Drug. Journal of Pharmaceutical Science
and Bio scientific Research, 2013; 3: 51-57.
11. Maffei Facino R, Carini M, Aldini G, Bombardelli E, Morazzoni P, et al. (1994) Free
radicals scavenging action and anti-enzyme activities of procyanidines from Vitis
vinifera. A mechanism for their capillary protective action. Arzneimittelforschung, 1994;
44: 592-601.
12. Loggia RD, Sosa S, Tubaro A et al., (1996). Anti-inflammatory activity of some gingko
biloba constituents and of their phospholipids-complexes. Fitoterapia., 3: 257-273.
13. Schmitt H. Lecithin and phospholipids – healthy and natural powerful nutrients. Wellness
Foods Europe 2008; NUMBER June/July: 24-9].
14. Manach C, Scalbert A, Morand C, Polyphenols, food sources and bioavailability,
American journal of clinical nutrition, 2004; 9: 727-747.
15. Thorne Research, Natural factors, and Naturesherb [Product-Information. Nefful's anti-
aging skin supplement-a natural skin regimen, the need for a natural antiaging skin
regimen. Available athttp://www.neffulusa.com/downloads/pdf/2009/A
R_Ingredient_Information.pdf: Accessed on 21st April 2011.].
16. N. Venkatesan, B. S. Babu, S. P. Vyas. Protected particulate drug carriers for prolonged
systemic circulation–a review. Indian J. Pharm. Sci., 2000; 62: 327-333.
17. M. A. Longer, H. S. Ching, J. R. Robinson. Oral delivery of chlorthiazide using a
bioadhesive polymer. J. Pharm. Sci., 1985; 74: 406-411.

www.wjpps.com Vol 7, Issue 10, 2018. 689


Patial et al. World Journal of Pharmacy and Pharmaceutical Sciences

18. S. Sharma, M. Sikarwar. Phytosome: a review. Planta Indica, 2005; 1: 1-3.


19. Jain NK. Liposomes as drug carriers, controlled and novel drug delivery, 1 st edition, CBS
publisher, 2005; 321-326.
20. Dayan N, Touitou E Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs.
liposomes. Biomaterials, 2000; 21: 1879-1885.
21. Srikanth V, Laxmaiah CH, Gopi SB, Naveen P, Chiranjeeb B, Shivaraj G. Phytosome: A
novel drug delivery system for improving bioavailability of herbal medicine. IJPRD.,
2011 Aug.; 3(6): 175-84.
22. Fry DW, White JC, Goldman ID. Rapid separation of low molecular weight solutes from
liposomes without dilution. Anal Biochem, 1978 Oct. 15; 90(2): 809-15.
23. Lars I, Martin B. Determination of the size distribution of liposomes by SEC
fractionation, and PCS analysis and enzymatic assay of lipid content. AAPS Pharm Sci
Tech., 2002 Jun; 3(2): 9.
24. Gregor C, Andreas S, Gabriele B. Transdermal drug carriers: Basic properties,
optimization and transfer efficiency in the case of epicutaneously applied peptides. J
Control Release., 1995 Sep.; 36(1-2): 3-16.
25. Van den Bergh BA, Swartzendruber DC, Bos-Van der Geest A, Hoogstraate JJ,
Schrijvers AH, Boddé HE et al. Development of an optimal protocol for the
ultrastructural examination of skin by transmission electron microscopy. J Microsc., 1997
Aug.; 187(Pt 2): 125-33.
26. Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs.
liposomes. Biomaterials, 2000 Sep.; 21(18): 1879-85.
27. Maffei Facino R, Carini M, Aldini G, Bombardelli E, Morazzoni P, Morelli R. Free
radicals scavenging action and anti-enzyme activities of procyanidines from Vitis
vinifera. A mechanism for their capillary protective action. Arzneimittelforschung, 1994
May; 44(5): 592-601.
28. Bombardelli E, Mustich G. Bilobalide-phospholipid comlex, their uses and formulation
containing them. U. S. Patent No. EPO-275005, 1991.
29. Gabetta B, Zini GF, Pifferi G. Spectroscopic Studies on Idb-1016 A New Flavanolignan
Complex. Plant Med., 1989; 55: 615.
30. Hou Z, Li Y, Huang Y, Zhou C, Lin J, Wang Y et al. Phytosomes loaded with mitomycin
C-soybean phosphatidylcholine complex developed for drug delivery. Mol Pharm., 2013
Jan 7; 10(1): 90-101.

www.wjpps.com Vol 7, Issue 10, 2018. 690


Patial et al. World Journal of Pharmacy and Pharmaceutical Sciences

31. Malandrino S, Pifferi G. Idb-1016 Silybin Phosphatidylcholine Complex. Drugs Future,


1990; 15: 226-7.
32. Havsteen BH. The biochemistry and medical significance of the flavonoids. Pharmacol &
Ther., 2002; 96: 67-202.
33. Saha S, Sarma A, Saikia P, Chakrabarty T (2013) Phytosome: A Brief Overview.
Scholars Academic Journal of Pharmacy, 2013; 2: 12-20.
34. Battacharya S (2009) Phytosome: Emerging strategy in delivery of herbal drugs and
nutraceuticals. Pharm Times., 2009; 41: 3.

www.wjpps.com Vol 7, Issue 10, 2018. 691

S-ar putea să vă placă și